Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Please check your cart before checkout to see availability and pricing
Additionally, there is a risk of contamination if individuals use non-sterile needles to inject the peptides
Full data from the trial results announced Thursday will be presented in June at the American Diabetes Association Scientific Sessions, Lilly said, and more results from the overall trial program will be announced and published later this year
Drug Categories Anti-obesity agents, Antidiabetic agents, Peptide therapeutics, Amylin analogues, GLP-1 receptor agonists Additional Notes Summary Table Disclaimer For Research Use Only
US$ 26.14
US$ 29.66
US$ 27.20
US$ 21.44
US$ 23.42
US$ 29.31
